
|Articles|March 11, 2010
Clinical Trial: A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
This clinical trial will evaluate the presence of recurrent or persistent Cushing's in patients who have undergone primary treatment for the condition.
Advertisement
Click
A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
Study Type: Observational
Age/Gender Requirements: 18 years+ (male/female)
Sponsor: Corcept Therapeutics
Purpose: To confirm “the presence of recurrent or persistent endogenous Cushing's syndrome in patients who have had primary surgical and/or radiation therapy for Cushing's disease and continue to manifest symptoms and signs of hypercortisolemia.”
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
ACHIEVE-5: Orforglipron Improves Glycemic Control, Weight in T2D on Basal Insulin
2
VESALIUS-CV: Evolocumab Reduces Cardiovascular Events in Patients With High-Risk Diabetes
3
GLP-1 Discontinuation Cuts Chances of Meeting Weight Loss, Glycemic Goals in T2D
4
Ecnoglutide Delivers 35% Greater Weight Loss Than Semaglutide in Head-to-Head Trial
5


























































